glp-1-based treatments approved for weight loss 2025 DrLeanaWen has written extensively about GLP-1 medicines, the blockbuster drugs including semaglutide and tirzepatide initially developed diabetes and now for obesity and several other chronic conditions. One in eight Americans Injectable GLP-1 drugs have transformed

Graves disease: Epidemiology, genetic and environmental risk factors and viruses

The most common adverse effects are gastrointestinal, including nausea, vomiting, and diarrhea

That question is driving growing interest among researchers studying the connection between GLP-1 drugs and Parkinsons disease

Copyright@2026 All Rights Reserved.

Clostridium butyricum produces the postbiotic butyrate which stimulates GLP-1. Bifidobacterium infantis produces the postbiotic acetate, and interacts with Akkermansia and Butyricum to promote an ecosystem in the gut that naturally boosts GLP-1

Other tissues, such as the myocardium and skeletal muscle, have no or very low BBD activity and are highly dependent on the uptake of carnitine from the blood [160]